Background*

Mr. Richard F. Pops has been the Chief Executive Officer of Alkermes PLC since September 11, 2009. Mr. Pops founded Genomics Collaborative, Inc. He Co-Founded Sirtris Pharmaceuticals, Inc. He served as the President of Alkermes PLC from September 11, 2009 to September 16, 2011 and previously served as its Chief Executive Officer from February 1991 to April 1, 2007. Prior to Alkermes, he was employed by PaineWebber Development Corporation as a Vice President. He has been ... the Chairman of Alkermes PLC since April 1, 2007 and has been its Director since February 1991. He has been a Director at Acceleron Pharma, Inc. since June 2004. He has been an Independent Director of Epizyme, Inc. since September 2008 and of Neurocrine Biosciences Inc. since April 16, 1998. He has been Member of Value and Coverage Advisory Council at FasterCures/The Center for Accelerating Medical Solutions since January 2015. He serves a Directors at New England Healthcare Institute (NEHI). He serves as Member of Advisory Board at Polaris Partners. Mr. Pops serves as a Trustee of Fessenden School, The. He serves on board of The Biotechnology Industry Organization (BIO); the Pharmaceutical Research and Manufacturers of America (PhRMA). He served as a Lead Director at Acceleron Pharma, Inc. since October 2007. He served as a Member of Harvard Medical School Board of Fellows. He served as a Member of Advisory Board at Polaris Venture Partners, Inc. He served as Director of Sirtris Pharmaceuticals, Inc from 2004 to 2008. He served as a Director of Expressive Constructs, Inc. He served as Director of Genomics Collaborative, Inc. He served as a Director of Zalicus Inc. (also known as CombinatoRx, Inc.) from October 2001 to December 2009 and Reliant Pharmaceuticals, Inc. since June 2006. He served as a Director at The Massachusetts Biotechnology Council. He served as Chair for the Harvard Medical School Advisory Council for Biological Chemistry & Molecular Pharmacology (BCMP). Mr. Pops received a B.A. in Economics from Stanford University in 1983.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.